Browse by Audience
Skip to content
Papers of the Week
Canine IL4-10 fusion protein provides disease modifying activity in a canine model of OA; an exploratory study.
Abstract
An ideal disease modifying osteoarthritis drug (DMOAD) has chondroprotective, anti-inflammatory, and analgesic effects. This study describes the production and characterization of a canine IL4-10 fusion protein (IL4-10 FP) and evaluates its in vivo DMOAD activity in a canine model of osteoarthritis (OA).